Neurodegenerative Disease Efficacy Evaluation

Neurodegenerative diseases, including Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), Parkinson's disease (PD), and Huntington's disease (HD), are irreversible disorders caused by the loss of neuronal structure or function. Our development of FAD4T (AD), SNCA (PD), TDP43 (ALS), SOD1 (ALS) and HTT (HD) mice, created as independent intellectual property, provides a behavioral analysis platform for the conduction of numerous tests, including the Morrise water maze, Y maze, and gait analysis. GemPharmatech additionally offers efficacy evaluation services for several neurodegenerative diseases to expedite the discovery of therapeutic drugs for these conditions.

TALK WITH OUR EXPERTS

GemPharmatech is committed to protecting and respecting your privacy, and we'll only use your personal information to administer your account and to provide the products and services you requested from us. From time to time, we would like to contact you about our products and services, as well as other content that may be of interest to you. If you consent to us contacting you for this purpose, please click below to say how you would like us to contact you:

In order to provide you with the content requested, we need to store and process your personal data. If you consent to us storing your personal data for this purpose, please click the checkbox below.

You can unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.